Nipocalimab and certolizumab combination therapy in participants with active rheumatoid arthritis despite prior treatment with advanced therapies: results from the phase 2a DAISY-RA study. [PDF]
Taylor PC +14 more
europepmc +1 more source
Anti-cyclic citrullinated peptide antibody in bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis. [PDF]
Mori R +5 more
europepmc +1 more source
Periodontitis and Rheumatoid Arthritis: Shared Pathophysiology, Bidirectional Association, and Therapeutic Implications-A Narrative Review. [PDF]
Najafimakhsoos N +4 more
europepmc +1 more source
Red Cell Distribution Width to Albumin Ratio: A Novel and Potential Biomarker for Rheumatoid Arthritis. [PDF]
Li X, Zhu H, Fu Y, Yin H.
europepmc +1 more source
First-line tumor necrosis factor inhibitor versus abatacept treatment choice in real-world patients with anticitrullinated protein antibody- and rheumatoid factor-positive rheumatoid arthritis. [PDF]
Lam G +11 more
europepmc +1 more source
Bone metabolism and inflammation drive structural damage in rheumatoid arthritis: clustering and multivariable analysis. [PDF]
Pollastri F +9 more
europepmc +1 more source
Multifactorial pathogenesis of rheumatoid arthritis: interaction between inflammation, metabolic dysregulation, and tissue mechanics. [PDF]
Xu Y +8 more
europepmc +1 more source
Clinical Factors Associated with hrCT-Confirmed Interstitial Lung Disease in Rheumatoid Arthritis: A Retrospective Case-Control Study. [PDF]
Dinache OG +4 more
europepmc +1 more source
Sublingual allergen immunotherapy in immunosuppressed rheumatoid arthritis patients: Safety and clinical outcomes. [PDF]
Kobayashi Y +7 more
europepmc +1 more source
Seronegative Rheumatoid Arthritis: A Distinct Immunopathological Entity with Erosive Potential. [PDF]
Lhotellerie F +3 more
europepmc +1 more source

